Spinal cord injury (SCI) can severely impair motor and autonomic function, with long-term consequences for quality of life. Epidural stimulation has emerged as a promising intervention, offering partial recovery by activating neural circuits below the injury. To make this therapy effective in practice, precise placement of stimulation electrodes is essential -- and that requires accurate segmentation of spinal cord structures in MRI data. We present a protocol for manual segmentation tailored to SCI anatomy, and evaluated a deep learning approach using a U-Net architecture to automate this segmentation process. Our approach yields accurate, efficient segmentation that identify potential electrode placement sites with high fidelity. Preliminary results suggest that this framework can accelerate SCI MRI analysis and improve planning for epidural stimulation, helping bridge the gap between advanced neurotechnologies and real-world clinical application with faster surgeries and more accurate electrode placement.

BackgroundCognitive dysfunction often co-occurs with psychopathology. Advances in neuroimaging and machine learning have led to neural indicators that predict individual differences in cognition with reasonable performance. We examined whether these neural indicators explain the relationship between cognition and mental health in the UK Biobank cohort (n > 14000). MethodsUsing machine learning, we quantified the covariation between general cognition and 133 mental health indices and derived neural indicators of cognition from 72 neuroimaging phenotypes across diffusion-weighted MRI (dwMRI), resting-state functional MRI (rsMRI), and structural MRI (sMRI). With commonality analyses, we investigated how much of the cognition-mental health covariation is captured by each neural indicator and neural indicators combined within and across MRI modalities. ResultsThe predictive association between mental health and cognition was at out-of-sample r = 0.3. Neuroimaging phenotypes captured 2.1% to 25.8% of the cognition-mental health covariation. The highest proportion of variance explained by dwMRI was attributed to the number of streamlines connecting cortical regions (19.3%), by rsMRI through functional connectivity between 55 large-scale networks (25.8%), and by sMRI via the volumetric characteristics of subcortical structures (21.8%). Combining neuroimaging phenotypes within modalities improved the explanation to 25.5% for dwMRI, 29.8% for rsMRI, and 31.6% for sMRI, and combining them across all MRI modalities enhanced the explanation to 48%. ConclusionsWe present an integrated approach to derive multimodal MRI markers of cognition that can be transdiagnostically linked to psychopathology. This demonstrates that the predictive ability of neural indicators extends beyond the prediction of cognition itself, enabling us to capture the cognition-mental health covariation.

Introduction and ObjectivesMany women with multiple sclerosis (MS) experience neurogenic overactive bladder (NOAB) characterized by urinary frequency, urinary urgency and urgency incontinence. The objective of the study was to create machine learning (ML) models utilizing clinical and imaging data to predict NOAB treatment success stratified by treatment type. MethodsThis was a retrospective cohort study of female patients with diagnosis of NOAB and MS seen at a tertiary academic center from 2017-2022. Clinical and imaging data were extracted. Three types of NOAB treatment options evaluated included behavioral therapy, medication therapy and minimally invasive therapies. The primary outcome - treatment success was defined as > 50% reduction in urinary frequency, urinary urgency or a subjective perception of treatment success. For the construction of the logistic regression ML models, bivariate analyses were performed with backward selection of variables with p-values of < 0.10 and clinically relevant variables applied. For ML, the cohort was split into a training dataset (70%) and a test dataset (30%). Area under the curve (AUC) scores are calculated to evaluate model performance. ResultsThe 110 patients included had a mean age of patients were 59 years old (SD 14 years), with a predominantly White cohort (91.8%), post-menopausal (68.2%). Patients were stratified by NOAB treatment therapy type received with 70 patients (63.6%) at behavioral therapy, 58 (52.7%) with medication therapy and 44 (40%) with minimally invasive therapies. On MRI brain imaging, 63.6% of patients had > 20 lesions though majority were not active lesions. The lesions were mostly located within the supratentorial (94.5%), infratentorial (68.2%) and 58.2 infratentorial brain (63.8%) as well as in the deep white matter (53.4%). For MRI spine imaging, most of the lesions were in the cervical spine (71.8%) followed by thoracic spine (43.7%) and lumbar spine (6.4%).10.3%). After feature selection, the top 10 highest ranking features were used to train complimentary LASSO-regularized logistic regression (LR) and extreme gradient-boosted tree (XGB) models. The top-performing LR models for predicting response to behavioral, medication, and minimally invasive therapies yielded AUC values of 0.74, 0.76, and 0.83, respectively. ConclusionsUsing these top-ranked features, LR models achieved AUC values of 0.74-0.83 for prediction of treatment success based on individual factors. Further prospective evaluation is needed to better characterize and validate these identified associations.

BackgroundGadolinium-based Contrast Agents (GBCAs) are used in brain MRI exams to improve the visualization of pathology and improve the delineation of lesions. Higher doses of GBCAs can improve lesion sensitivity but involve substantial deviation from standard-of-care procedures and may have safety implications, particularly in the light of recent findings on gadolinium retention and deposition. PurposeTo evaluate the clinical performance of an FDA cleared deep-learning (DL) based contrast boosting algorithm in routine clinical brain MRI exams. MethodsA multi-center retrospective database of contrast-enhanced brain MRI images (obtained from April 2017 to December 2023) was used to evaluate a DL-based contrast boosting algorithm. Pre-contrast and standard post-contrast (SC) images were processed with the algorithm to obtain contrast boosted (CB) images. Quantitative performance of CB images in comparison to SC images was compared using contrast-to-noise ratio (CNR), lesion-to-brain ratio (LBR) and contrast enhancement percentage (CEP). Three board-certified radiologists reviewed CB and SC images side-by-side for qualitative evaluation and rated them on a 4-point Likert scale for lesion contrast enhancement, border delineation, internal morphology, overall image quality, presence of artefacts, and changes in vessel conspicuity. The presence, cause, and severity of any false lesions was recorded. CB results were compared to SC using Wilcoxon signed rank test for statistical significance. ResultsBrain MRI images from 110 patients (47 {+/-} 22 years; 52 Females, 47 Males, 11 N/A) were evaluated. CB images had superior quantitative performance than SC images in terms of CNR (+634%), LBR (+70%) and CEP (+150%). In the qualitative assessment CB images showed better lesion visualization (3.73 vs 3.16) and had better image quality (3.55 vs 3.07). Readers were able to rule out all false lesions on CB by using SC for comparison. ConclusionsDeep learning based contrast boosting improves lesion visualization and image quality without increasing contrast dosage. Key ResultsO_LIIn a retrospective study of 110 patients, deep-learning based contrast boosted (CB) images showed better lesion visualization than standard post-contrast (SC) brain MRI images (3.73 vs 3.16; mean reader scores [4-point Likert scale]) C_LIO_LICB images had better overall image quality than SC images (3.55 vs 3.07) C_LIO_LIContrast-to-noise ratio, Lesion-to-brain Ratio and Contrast Enhancement Percentage for CB images were significantly higher than SC images (+729%, +88% and +165%; p < 0.001) C_LI Summary StatementDeep-learning based contrast boosting achieves better lesion visualization and overall image quality and provides more contrast information, without increasing the contrast dosage in contrast-enhanced brain MR protocols.

IntroductionAccurately predicting Alzheimers Disease (AD) progression is useful for clinical care. The 2019 TADPOLE (The Alzheimers Disease Prediction Of Longitudinal Evolution) challenge evaluated 92 algorithms from 33 teams worldwide. Unlike typical clinical prediction studies, TADPOLE accommodates (1) variable number of observed timepoints across patients, (2) missing data across modalities and visits, and (3) prediction over an open-ended time horizon, which better reflects real-world data. However, TADPOLE only used the Alzheimers Disease Neuroimaging Initiative (ADNI) dataset, so how well top algorithms generalize to other cohorts remains unclear. MethodsWe tested five algorithms in three external datasets covering 2,312 participants and 13,200 timepoints. The algorithms included FROG, the overall TADPOLE winner, which utilized a unique Longitudinal-to-Cross-sectional (L2C) transformation to convert variable-length longitudinal histories into feature vectors of the same length across participants (i.e., same-length feature vectors). We also considered two FROG variants. One variant unified all XGBoost models from the original FROG with a single feedforward neural network (FNN), which we referred to as L2C-FNN. We also included minimal recurrent neural networks (MinimalRNN), which was ranked second at publication time, as well as AD Course Map (AD-Map), which outperformed MinimalRNN at publication time. All five models - three FROG variants, MinimalRNN and AD-Map - were trained on ADNI and tested on the external datasets. ResultsL2C-FNN performed the best overall. In the case of predicting cognition and ventricle volume, L2C-FNN and AD-Map were the best. For clinical diagnosis prediction, L2C-FNN was the best, while AD-Map was the worst. L2C-FNN also maintained its edge over other models, regardless of the number of observed timepoints, and regardless of the prediction horizon from 0 to 6 years into the future. ConclusionsL2C-FNN shows strong potential for both short-term and long-term dementia progression prediction. Pretrained ADNI models are available: https://github.com/ThomasYeoLab/CBIG/tree/master/stable_projects/predict_phenotypes/Zhang2025_L2CFNN.

IntroductionThe assessment of vestibular schwannoma (VS) requires a standardized measurement approach as growth is a key element in defining treatment strategy for VS. Volumetric measurements offer higher sensitivity and precision, but existing methods of segmentation, are labour-intensive, lack standardisation and are prone to variability and subjectivity. A new core set of measurement indicators reported consistently, will support clinical decision-making and facilitate evidence synthesis. This systematic review aimed to identify indicators used in 1) magnetic resonance imaging (MRI) acquisition and 2) measurement or 3) growth of VS. This work is expected to inform a Delphi consensus. MethodsSystematic searches of Medline, Embase and Cochrane Central were undertaken on 4th October 2024. Studies that assessed the evaluation of VS with MRI, between 2014 and 2024 were included. ResultsThe final dataset consisted of 102 studies and 19001 patients. Eighty-six (84.3%) studies employed post contrast T1 as the MRI acquisition of choice for evaluating VS. Nine (8.8%) studies additionally employed heavily weighted T2 sequences such as constructive interference in steady state (CISS) and FIESTA-C. Only 45 (44.1%) studies reported the slice thickness with the majority 38 (84.4%) choosing <3mm in thickness. Fifty-eight (56.8%) studies measured volume whilst 49 (48.0%) measured the largest linear dimension; 14 (13.7%) studies used both measurements. Four studies employed semi-automated or automated segmentation processes to measure the volumes of VS. Of 68 studies investigating growth, 54 (79.4%) provided a threshold. Significant variation in volumetric growth was observed but the threshold for significant percentage change reported by most studies was 20% (n = 18). ConclusionSubstantial variation in MRI acquisition, and methods for evaluating measurement and growth of VS, exists across the literature. This lack of standardization is likely attributed to resource constraints and the fact that currently available volumetric segmentation methods are very labour-intensive. Following the identification of the indicators employed in the literature, this study aims to develop a Delphi consensus for the standardized measurement of VS and uptake in employing a data-driven artificial intelligence-based measuring tools.

Body mass index (BMI) does not account for substantial inter-individual differences in regional fat and muscle compartments, which are relevant for the prevalence of cardiometabolic and cancer conditions. We applied a validated deep learning pipeline for automated segmentation of whole-body MRI scans in 45,851 adults from the UK Biobank and German National Cohort, enabling harmonized quantification of visceral (VAT), gluteofemoral (GFAT), and abdominal subcutaneous adipose tissue (ASAT), liver fat fraction (LFF), and trunk muscle volume. Associations with clinical conditions were evaluated using compartment measures adjusted for age, sex, height, and BMI. Our analysis demonstrates that regional adiposity and muscle volume show distinct associations with cardiometabolic and cancer prevalence, and that substantial disease heterogeneity exists within BMI strata. The analytic framework and reference data presented here will support future risk stratification efforts and facilitate the integration of automated MRI phenotyping into large-scale population and clinical research.

Glaucoma is increasingly recognized as a neurodegenerative condition involving both retinal and central nervous system structures. Here, we present an integrated framework that combines MK-Curve-corrected diffusion kurtosis imaging (DKI), tractometry, and deep autoencoder-based normative modeling to detect localized white matter abnormalities associated with glaucoma. Using UK Biobank diffusion MRI data, we show that MK-Curve approach corrects anatomically implausible values and improves the reliability of DKI metrics - particularly mean (MK), radial (RK), and axial kurtosis (AK) - in regions of complex fiber architecture. Tractometry revealed reduced MK in glaucoma patients along the optic radiation, inferior longitudinal fasciculus, and inferior fronto-occipital fasciculus, but not in a non-visual control tract, supporting disease specificity. These abnormalities were spatially localized, with significant changes observed at multiple points along the tracts. MK demonstrated greater sensitivity than MD and exhibited altered distributional features, reflecting microstructural heterogeneity not captured by standard metrics. Node-wise MK values in the right optic radiation showed weak but significant correlations with retinal OCT measures (ganglion cell layer and retinal nerve fiber layer thickness), reinforcing the biological relevance of these findings. Deep autoencoder-based modeling further enabled subject-level anomaly detection that aligned spatially with group-level changes and outperformed traditional approaches. Together, our results highlight the potential of advanced diffusion modeling and deep learning for sensitive, individualized detection of glaucomatous neurodegeneration and support their integration into future multimodal imaging pipelines in neuro-ophthalmology.

ObjectiveMagnetic Resonance Diffusion-Weighted Imaging (DWI) is a crucial tool for diagnosing acute ischemic stroke, yet some patients present as DWI-negative. This study aims to analyze the imaging differences and associated clinical characteristics in acute ischemic stroke patients receiving intravenous thrombolysis, in order to enhance understanding of DWI-negative strokes. MethodsRetrospective collection of clinical data from acute ischemic stroke patients receiving intravenous thrombolysis at the Stroke Center of the First Affiliated Hospital of Chongqing Medical University from January 2017 to June 2023, categorized into DWI-positive and negative groups. Descriptive statistics, univariate analysis, binary logistic regression, and machine learning model were utilized to assess the predictive value of clinical features. Additionally, telephone follow-up was conducted for DWI-negative patients to record medication compliance, stroke recurrence, and mortality, with Fine-Gray competing risk model used to analyze recurrent risk factors. ResultsThe incidence rate of DWI-negative ischemic stroke is 22.74%. Factors positively associated with DWI-positive cases include onset to needle time (ONT), onset to first MRI time (OMT), NIHSS score at 1 week of hospitalization (NIHSS-1w), hyperlipidemia (HLP), and atrial fibrillation (AF) (p<0.05, OR>1). Conversely, recurrent ischemic stroke (RIS) and platelet count (PLT) are negatively correlated with DWI-positive cases (p<0.05, OR<1). Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification significantly influences DWI presentation (p=0.01), but the specific impact of etiological subtypes remains unclear. Machine learning models suggest that the features with the highest predictive value, in descending order, are AF, HLP, OMT, ONT, NIHSS difference within 24 hours post-thrombolysis(NIHSS-d(0-24h)PT), and RIS. ConclusionsNIHSS-1w, OMT, ONT, HLP, and AF can predict DWI-positive findings, while platelet count and RIS are associated with DWI-negative cases. AF and HLP demonstrate the highest predictive value. DWI-negative patients have a higher risk of stroke recurrence than mortality in the short term, with a potential correlation between TOAST classification and recurrence risk.

While Deep Learning (DL) models trained on Magnetic Resonance Imaging (MRI) have shown promise for prostate cancer detection, their lack of direct biological validation often undermines radiologists trust and hinders clinical adoption. Radiologic-histopathologic (rad-path) correlation has the potential to validate MRI-based lesion detection using digital histopathology. This study uses automated and manually annotated digital histopathology slides as a standard of reference to evaluate the spatial extent of lesion annotations derived from both radiologist interpretations and DL models previously trained on prostate bi-parametric MRI (bp-MRI). 117 histopathology slides were used as reference. Prospective patients with clinically significant prostate cancer performed a bp-MRI examination before undergoing a robotic radical prostatectomy, and each prostate specimen was sliced using a 3D-printed patient-specific mold to ensure a direct comparison between pre-operative imaging and histopathology slides. The histopathology slides and their corresponding T2-weighted MRI images were co-registered. We trained DL models for cancer detection on large retrospective datasets of T2-w MRI only, bp-MRI and histopathology images and did inference in a prospective patient cohort. We evaluated the spatial extent between detected lesions and between detected lesions and the histopathological and radiological ground-truth, using the Dice similarity coefficient (DSC). The DL models trained on digital histopathology tiles and MRI images demonstrated promising capabilities in lesion detection. A low overlap was observed between the lesion detection masks generated by the histopathology and bp-MRI models, with a DSC = 0.10. However, the overlap was equivalent (DSC = 0.08) between radiologist annotations and histopathology ground truth. A rad-path correlation pipeline was established in a prospective patient cohort with prostate cancer undergoing surgery. The correlation between rad-path DL models was low but comparable to the overlap between annotations. While DL models show promise in prostate cancer detection, challenges remain in integrating MRI-based predictions with histopathological findings.